Saturday, December 6, 2025

Kim’s Midnight Madness: A Nuclear ICBM Parade That Defies Washington and Seoul

North Korea's 80th Workers' Party anniversary features military parades and international diplomacy, showcasing advanced weaponry and alliances.

Unification Ministry Notes Kim Jong Un Absent from Latest Artillery Training

North Korea conducted artillery drills, but South Korea assesses them as not large-scale, especially without Kim Jong Un's presence.

High-Stakes Power Struggle Unfolds at HYBE

Amidst allegations of an attempt by ADOR...

Tag: Eli Lilly

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.